High Tower Advisors, LLC Emergent Bio Solutions Inc. Transaction History

High Tower Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$56.61 - $80.46 $180,302 - $256,265	-3,185 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$86.23 - $125.19 $6,294 - $9,138	73 Added 2.35%	3,185 $295,000
Q4 2020 Feb 10, 2021	BUY	$79.17 - $111.47 $34,122 - $48,043	431 Added 16.08%	3,112 $280,000
Q3 2020 Nov 13, 2020	SELL	$81.91 - $134.94 $226,808 - $373,648	-2,769 Reduced 50.81%	2,681 $278,000
Q2 2020 Aug 10, 2020	BUY	$54.33 - $89.52 $597 - $984	11 Added 0.2%	5,450 $430,000
Q1 2020 May 21, 2020	BUY	$49.34 - $68.76 $28,913 - $40,293	586 Added 12.08%	5,439 $314,000
Q4 2019 Feb 14, 2020	BUY	$51.21 - $59.06 $52,131 - $60,123	1,018 Added 26.54%	4,853 $262,000
Q3 2019 Nov 12, 2019	BUY	$40.6 - $57.2 $155,701 - $219,362	3,835 New	3,835 $201,000
Q4 2018 Feb 14, 2019	SELL	$55.63 - $73.24 $297,286 - $391,394	-5,344 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$52.05 - $66.51 $278,155 - $355,429	5,344 New	5,344 $359,000

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $500M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.